Parkinson Disease (PD)
59
21
25
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 59 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (59)
GBPDC: Gut-Brain in PD Consortium Master Protocol
A Trial to Evaluate Safety and Efficacy of a Product Named VGN-R08b in Parkinson's Disease Patients With GBA1 Mutations
Virtual Reality on Balance of Parkinson's Disease
Evaluation of the Effects of Levodopa-Benserazide Drug Combination on Periodontal Status in Patients With Parkinson's Disease
Effects of Dual-Task Training on Upper Extremity Function in Parkinson's Disease
Real World Outcomes of Intranasal MuSE Exosomes and Stem Cells in Neurological Regenerative Therapy
Effect of Motor Imagery Added to Rehabilitation on Balance and Kinesiophobia in Patients With Parkinson's Disease
Exercise Management in Parkinson's Disease
Enhancing Nursing Students' Empathy and Learning in Parkinson's Disease Through High-Fidelity Simulation and Blended Learning
Inhibitory Control and Gait Adaptability in Parkinson's Disease
18F-mFBG Cardiac Uptake With Lewy Body Dementia
Nut Consumption and Prevention of Non-communicable Diseases: A Global Individual Participant Data Meta-analysis
Effects of a Multicomponent Protocol With Emphasis on Muscle Power Training on Bradykinesia in Individuals With Parkinson's Disease
Motor and Cognitive Exercise in Parkinson's Disease.
Validation of α-synuclein Modifications in Parkinson's dIsoRder Evolution
Clinical Validity of the DANU Sports System for Gait and Balance Assessment in Parkinson's Disease
Effects of Transcranial Direct Current Stimulation Combined With Nordic Walking on Gait and Balance in Parkinson's Disease
Behavioral Intervention for Lifestyle Physical Activity in Parkinson's Disease
D-SPARK: A Clinical Trial of D-Serine for Modifying Parkinson's Disease Progression
Sensor-Based Optimization of Therapy for Parkinson's Disease Patients With Motor Fluctuations